Cazzola, M <br/><br/>
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.  [electronic resource] 

 -  European journal of clinical pharmacology  Jan 1999 
 - 829-33 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0031-6970 
<br/><br/><label>Standard No.: </label>10.1007/s002280050561  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Albuterol--administration & dosage<br/>Arrhythmias, Cardiac--chemically induced<br/>Bronchodilator Agents--adverse effects<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Forced Expiratory Flow Rates--drug effects<br/>Forced Expiratory Volume--drug effects<br/>Heart Rate--drug effects<br/>Humans<br/>Lung Diseases, Obstructive--drug therapy<br/>Male<br/>Middle Aged<br/>Salmeterol Xinafoate<br/>Terbutaline--administration & dosage<br/>Time Factors<br/>Tremor--chemically induced